Cardiogenic Shock Following Acute Myocardial Infarction: A Retrospective Observational Study

Roxana Sadeghi, Naser Kachoueian, Zohreh Maghsoomi, Mohammad Sistanizad, Zahra Soroureddin, M. Akbarzadeh
{"title":"Cardiogenic Shock Following Acute Myocardial Infarction: A Retrospective Observational Study","authors":"Roxana Sadeghi, Naser Kachoueian, Zohreh Maghsoomi, Mohammad Sistanizad, Zahra Soroureddin, M. Akbarzadeh","doi":"10.29252/IJCP-27631","DOIUrl":null,"url":null,"abstract":"Introduction: Cardiogenic shock is a sudden complication that occurs in 5 to 10% of patients with acute myocardial infarction. According to statistics, mortality and morbidity from this event, despite all hospital care, are approximately 70-80%. Methods : This study was conducted over three years (2012 to 2014) in 28 cases of acute myocardial infarction, which was complicated by cardiovascular shock, before or after admission. We compared the outcomes of patients according to the treatment strategy, thrombolytic therapy, primary percutaneous coronary intervention (PCI), or other medical stabilization. The 30-day follow-up was the first endpoint, and the 3- month follow up was the second endpoint of the study. Results : 28 patients with cardiogenic shock included in this study. The mean (± SD) age of the patients was 62.99 ± 13.99 years. The median time to the onset of shock was 648.75 ± 1393.58 minutes after infarction. Most of the patients who underwent coronary angiography had 3-vessel or left main involvement. Two patients missed in follow up and five (80%) patients who received thrombolytic therapy passed away. Nine (100%) patients in the medical stabilization group and six patients (50%) underwent primary PCI group passed away too. The mortality in the primary PCI group was significantly lower than the other groups (P = 0.04). Conclusion: Although cardiogenic shock is a potential risk of early death, it is important that the thrombolytic in these patients doesn't increase survival and the primary PCI is more effective than thrombolytic agents.","PeriodicalId":31436,"journal":{"name":"International Journal of Cardiovascular Practice","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cardiovascular Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29252/IJCP-27631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Cardiogenic shock is a sudden complication that occurs in 5 to 10% of patients with acute myocardial infarction. According to statistics, mortality and morbidity from this event, despite all hospital care, are approximately 70-80%. Methods : This study was conducted over three years (2012 to 2014) in 28 cases of acute myocardial infarction, which was complicated by cardiovascular shock, before or after admission. We compared the outcomes of patients according to the treatment strategy, thrombolytic therapy, primary percutaneous coronary intervention (PCI), or other medical stabilization. The 30-day follow-up was the first endpoint, and the 3- month follow up was the second endpoint of the study. Results : 28 patients with cardiogenic shock included in this study. The mean (± SD) age of the patients was 62.99 ± 13.99 years. The median time to the onset of shock was 648.75 ± 1393.58 minutes after infarction. Most of the patients who underwent coronary angiography had 3-vessel or left main involvement. Two patients missed in follow up and five (80%) patients who received thrombolytic therapy passed away. Nine (100%) patients in the medical stabilization group and six patients (50%) underwent primary PCI group passed away too. The mortality in the primary PCI group was significantly lower than the other groups (P = 0.04). Conclusion: Although cardiogenic shock is a potential risk of early death, it is important that the thrombolytic in these patients doesn't increase survival and the primary PCI is more effective than thrombolytic agents.
急性心肌梗死后心源性休克:一项回顾性观察研究
心源性休克是一种突发并发症,发生在5 - 10%的急性心肌梗死患者中。据统计,尽管在医院接受了所有治疗,但这一事件的死亡率和发病率约为70-80%。方法:对28例住院前后合并心血管性休克的急性心肌梗死患者(2012 ~ 2014年)进行为期3年的研究。我们根据治疗策略、溶栓治疗、初级经皮冠状动脉介入治疗(PCI)或其他药物稳定来比较患者的结果。30天的随访是第一个终点,3个月的随访是第二个终点。结果:本研究纳入28例心源性休克患者。患者平均(±SD)年龄为62.99±13.99岁。梗死后至休克发作的中位时间为648.75±1393.58分钟。大多数接受冠状动脉造影的患者有三支血管或左主干受累。2例患者未随访,5例(80%)接受溶栓治疗患者死亡。药物稳定组9例(100%)和首次PCI组6例(50%)患者死亡。首次PCI组病死率明显低于其他各组(P = 0.04)。结论:虽然心源性休克是早期死亡的潜在风险,但重要的是这些患者的溶栓不会增加生存率,并且初次PCI比溶栓药物更有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
4
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信